Contact
Please use this form to send email to PR contact of this press release:
FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease
TO:
Please use this form to send email to PR contact of this press release:
FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease
TO: